Deakin University, Institute for Physical Activity and Nutrition (IPAN), School of Exercise and Nutrition Sciences, Geelong, Australia.
Deakin University, Food & Mood Centre, IMPACT Strategic Research Centre, School of Medicine, Geelong, Australia.
Neurosci Biobehav Rev. 2020 May;112:227-241. doi: 10.1016/j.neubiorev.2020.02.003. Epub 2020 Feb 4.
The 'Dual Hit' hypothesis, stating that Parkinson's disease (PD) begins via olfactory pathways and the gut, and the gastrointestinal symptoms PD individuals face, have largely driven the interest of the gut's involvement in PD. Studies have since observed gut microbiota differences between PD groups and controls, with these alterations potentially relating to PD pathophysiology. However, differences in the studies' methodologies precludes unanimity on the relationships of gut microbiota to PD. Thirteen observational case-control studies investigating gut microbiota in PD and controls were reviewed to assess how microbiota abundance and diversity relates to PD. Nine studies showed butyrate producing gut microbiota had lower abundances in PD compared to controls. Three studies reported α-diversity was higher, with one reporting it was lower, in PD compared to controls. Given most studies show abundance, not diversity, differences of butyrate producing bacteria between groups, we propose abundance differences are more associated with PD than microbiota diversity. As current research is observational, investigating how specific bacteria and their metabolites may alter throughout PD progression is warranted.
“双重打击”假说指出,帕金森病(PD)始于嗅觉通路和肠道,而 PD 患者面临的胃肠道症状在很大程度上推动了人们对肠道参与 PD 的兴趣。此后,研究观察到 PD 组和对照组之间的肠道微生物群差异,这些改变可能与 PD 病理生理学有关。然而,由于研究方法的差异,肠道微生物群与 PD 的关系尚无定论。本文综述了 13 项观察性病例对照研究,旨在评估肠道微生物群丰度和多样性与 PD 的关系。有 9 项研究表明,与对照组相比,PD 患者体内产生丁酸盐的肠道微生物群丰度较低。有 3 项研究报告称,PD 患者的 α 多样性较高,而有 1 项研究报告称,PD 患者的 α 多样性较低。鉴于大多数研究表明,与对照组相比,产生丁酸盐的细菌在数量上存在差异,而不是多样性上存在差异,因此我们认为,与肠道微生物群多样性相比,数量上的差异与 PD 的关系更为密切。由于目前的研究是观察性的,因此有必要研究特定细菌及其代谢物如何在 PD 进展过程中发生变化。